Research Article
[Retracted] Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
Table 5
Comparison of adverse reactions between the two groups.
| | Group | Gastrointestinal reaction | Fatigue | Anemia | Neutropenia | Hypertension | Proteinuria |
| | Observation group () | 7 (16.67) | 22 (52.38) | 17 (40.48) | 8 (19.05) | 19 (45.24) | 4 (9.52) | | Control group () | 8 (19.05) | 25 (59.52) | 12 (28.57) | 7 (16.67) | 25 (59.52) | 7 (16.67) | | 0.081 | 0.435 | 1.317 | 0.081 | 1.718 | 0.941 | | 0.776 | 0.510 | 0.251 | 0.776 | 0.190 | 0.332 |
|
|
